| Term 
 | Definition 
 
        | Alpha 1 agonists Characteristics -weak β effects - not metabolized by COMT so longer 1/2 life Uses - nasal decongestant - hypotension: increases BP w/ little cardiac effect at normal doses - shock Effects - dilates pupils - induces reflex bradycardia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α1 agonist Characteristics - no β effects - not a substrate for MAO of COMT Uses - hypotension Effects - induces reflex bradycardia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α2 agonist Characteristics - acts at α2 receptors in brainstem to lower sympathetic outflow and lower BP   - causes acute rise in BP followed by prolonged hypotension Uses - antihypertensive agent Effects - rebound hypertension possible so patient must be weaned off slowly |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |  β1 agonist Characteristics: - inotropic: raises HR and contractility - also acts on α1 and β2 receptors    Uses: -CHF Side effects - α1 action causes vasoconstriction and could be potentially harmful in kidneys but β2 action causes vasodilation and counteracts                  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | β2 agonists Characteristics: - selective β-agonist, doesn't affect heart (β1) Uses: - bronchodilator for asthma or COPD-related bronchoconstriction - may be used to induce labor Side effects: - inhibits mast cell secretion (?) - Not metabolized by MAO or COMT = long 1/2-life |  | 
        |  | 
        
        | Term 
 
        | Amphetamines - Dexedrine - Methamphetamine |  | Definition 
 
        | Indirect agonist - promotes NE release = α and β1 Characteristics - Similar to NE effects but is a CNS stimulant b/c it can cross BBB unline NE Uses: - increases alertness, decreases fatigue, enhances physical and mental performance Side effects: - increased systolic and diastolic BP - can also lead to appetite suppression but tolerance is reached |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mixed acting agonist - direct and indirect effects Characteristics: - Direct - stimulates α1 receptors and weak β-effect - Indirect - false neurotransmitter that replaces NE in storage granules Uses: - treatment for hypotension (e.g. shock) Side effects: - effects similar to NE = increased BP |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mixed-acting agonist - direct and indirect effects Characteristics: - Direct - stimulates α and β receptors - Indirect - induces NE release like amphetamines and stimulates CNS Uses: - appetite supressant - more effective w/ caffeine - pseudoephedrine used as nasal decongestant due to α effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α antagonist Characteristics: - irreversible block, esp α1 which has more effect on smooth muscle Uses: - Pheochromocytoma: prevents HTN crisis from α receptor overstimulation; preoperative - autonomic hyperreflexia - Benign prostatic hypertrophy: relieves urine obstruction Side effects: - orthostatic hypotension - reflex tachycardia - nasal congestion - side effects of impaired smooth muscle contraction  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α antagonist Characteristics: - non-selective, competitive α1 & 2 antagonist Uses: - ED - Pheochromocytoma - induced hypertention - not a general anti-HTN due to s/e Side effects: - orthostatic hypotension - reflex tachycardia - nasal congestion - limited clinical use due to action on other receptors like serotonin, K channels - histamine release from mast cells |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α-antagonist Characteristics: - selective for α1 antagonism and inhibition of cyclic phosphodiesterase (PDE) - direct vasodilatory effect via α1 antagonism - decreased peripheral resistance due to PDE inhibition Uses: - treat hypertension - improved urinary flow in BPH (esp terazosin) Side effects: - first dose phenomenon: dizziness and postural syncope -take before bedtime  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | β-antagonist Characteristics: - competitive antagonists of both β1 and β2 receptors - decreases HR, contractility, and peripheral vascular resistance Uses: - treat hypertension - MI and post-MI patients (reduces O2 requirement) - glaucoma: decreased aqueous humor secretion - hyperthyroidism- reduces symptoms caused by Side effects: - lead to bronchoconstriction in patients with COPD, asthma - hypoglycemia in diabetics |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | β-antagonists Characteristics: - competitive antagonists of β1 receptor - decreases HR, contractility and peripheral vascular resistance Uses: - Hypertension - ischemic heart disease Side effects: - less tendency for bronchoconstriction due to lack of β2 block |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibit NE release and storage Characteristics: - depletes NE from presynaptic neuron and inhibits its release - does not cross BBB Uses: - hypertension: dilates arterial and venous beds Side effects: - orthostatic hypotension - GI problems: diarrhea due to decreased sympathetics = parasympathetic hypermotility - male sexual disturbances (retrograde ejaculation) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits NE release and storage Characteristics: - irreversible inhibition of dopamine and NE uptake into storage vesicles which blocks NE storage and synthesis but not NE release; MAO/COMT degrade NE and Dopamine in cytosol Uses: - mild to moderate hypertension Side effects: - less orthostatic hypotension - crosses BBB --> CNS effects:    ~depression, sedation, nightmares, suicidal thoughts   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acts as a "false-neurotransmitter" Characteristics: - creates false NE - mimics DOPA and is incorporated during NE synthesis Uses: - Hypertension but due to CNS action rather than peripheral action   ~good for pregnant women and renal disease patients Side effects: - due to CNS action    ~ sedation, drowsiness, orthostatic hypotension, nasal congestion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits NE synthesis Characteristics: - inhibits tyrosine hydroxylase to stop synthesis of catecholamines Uses: - pheochromocytoma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits Uptake 1 Characteristics: - inhibition of Uptake 1 causese NE accumulation in synaptic cleft and overstimulation of postsynaptic receptor Uses: - local anesthetic Side effects: - many but will be covered in neuroscience lectures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Phenylephrine Methoxamine   - cause vasoconstriction     |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dobutamine   -increases myocardial contractility |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Terbutaline Albuterol   -smooth muscle dilators |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Amphetamines - Dexedrine - Methamphetamine   -cause release of NE |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Metaraminol Ephedrine   - have both direct and indirect agonistic effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Phenoxybenzamine Phentolamine Prazosin |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Indirect adrenergic agents - Inhibit NE synthesis and storage |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Indirect adrenergic agents - False neurotransmitters |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Indirect adrenergic agents - Inhibits NE synthesis |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Indirect adrenergic agents - Inhibits Uptake 1 |  | Definition 
 | 
        |  |